BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

17 related articles for article (PubMed ID: 38580334)

  • 1. Activation and transcriptional profile of monocytes and CD8
    Gudd CLC; Au L; Triantafyllou E; Shum B; Liu T; Nathwani R; Kumar N; Mukherjee S; Dhar A; Woollard KJ; Yone Y; Pinato DJ; Thursz MR; Goldin RD; Gore ME; Larkin J; Khamri W; Antoniades CG; Turajlic S; Possamai LA
    J Hepatol; 2021 Jul; 75(1):177-189. PubMed ID: 33631227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte-derived macrophages contribute to the deterioration of immunological liver injury in mice.
    Ruiqi W; Xiaoli F; Leyu Z; Mengyi S; Qiaoyu D; Yanyi Z; Li Y
    Int Immunopharmacol; 2023 Nov; 124(Pt B):111036. PubMed ID: 37832236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury.
    Puengel T; Krenkel O; Kohlhepp M; Lefebvre E; Luedde T; Trautwein C; Tacke F
    PLoS One; 2017; 12(9):e0184694. PubMed ID: 28910354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in Mice.
    Ambade A; Lowe P; Kodys K; Catalano D; Gyongyosi B; Cho Y; Iracheta-Vellve A; Adejumo A; Saha B; Calenda C; Mehta J; Lefebvre E; Vig P; Szabo G
    Hepatology; 2019 Mar; 69(3):1105-1121. PubMed ID: 30179264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of Pathogenic Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis.
    Ma P; Liu J; Qin J; Lai L; Heo GS; Luehmann H; Sultan D; Bredemeyer A; Bajapa G; Feng G; Jimenez J; He R; Parks A; Amrute J; Villanueva A; Liu Y; Lin CY; Mack M; Amancherla K; Moslehi J; Lavine KJ
    Circulation; 2024 Jan; 149(1):48-66. PubMed ID: 37746718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic inhibition of monocyte recruitment prevents checkpoint inhibitor-induced hepatitis.
    Gudd CLC; Mitchell E; Atkinson SR; Mawhin MA; Turajlic S; Larkin J; Thursz MR; Goldin RD; Powell N; Antoniades CG; Woollard KJ; Possamai LA; Triantafyllou E
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38580334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-related adverse events in checkpoint blockade: Observations from human tissue and therapeutic considerations.
    Williams KC; Gault A; Anderson AE; Stewart CJ; Lamb CA; Speight RA; Rajan N; Plummer R; Pratt AG
    Front Immunol; 2023; 14():1122430. PubMed ID: 36776862
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.